IDH1 and IDH2 Driven Intrahepatic Cholangiocarcinoma (IHCC): A comprehensive genomic and immune profiling study.

被引：8
|
作者：
Makawita, Shalini
Borad, Mitesh J.
Carapeto, Fernando
Kwong, Lawrence
Bekaii-Saab, Tanios S.
Murugesan, Karthikeyan
Ross, Jeffrey S.
Danziger, Natalie
Israel, Mason A.
McGregor, Kimberly
Janku, Filip
Javle, Milind M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA
[4] Fdn Med Inc, Cambridge, MA USA
[5] Fdn Med, Cambridge, MA USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.4009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4009
引用
收藏
页数：3
相关论文
共 50 条
  • [41] IDH1 and IDH2 mutations in Bulgarian patients with glial tumours
    Goranova, T.
    Stancheva, G.
    Mitkova, A.
    Kaneva, R.
    Poptodorov, G.
    Velinov, N.
    Mitev, V.
    Gabrovsky, N.
    EJC SUPPLEMENTS, 2010, 8 (05): : 224 - 225
  • [42] IDH1 and IDH2 mutations are rare in pediatric myeloid malignancies
    Oki, K.
    Takita, J.
    Hiwatari, M.
    Nishimura, R.
    Sanada, M.
    Okubo, J.
    Adachi, M.
    Sotomatsu, M.
    Kikuchi, A.
    Igarashi, T.
    Hayashi, Y.
    Ogawa, S.
    LEUKEMIA, 2011, 25 (02) : 382 - +
  • [43] IDH1/IDH2 mutations predict survival in glioma and AML
    Hegi, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S2 - S2
  • [44] Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report
    Haider, Ali S.
    Ene, Chibawanye I.
    Palmisciano, Paolo
    Haider, Maryam
    Rao, Ganesh
    Ballester, Leomar Y.
    Fuller, Gregory N.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [45] Mutations in the Isocitrate Dehydrogenase Genes IDH1 and IDH2 in Tumors
    Schaap, Frank G.
    French, Pim J.
    Bovee, Judith V. M. G.
    ADVANCES IN ANATOMIC PATHOLOGY, 2013, 20 (01) : 32 - 38
  • [46] IDH1 and IDH2 hotspot mutations are not found in canine glioma
    Reitman, Zachary J.
    Olby, Natasha J.
    Mariani, Christopher L.
    Thomas, Rachael
    Breen, Matthew
    Bigner, Darell D.
    McLendon, Roger E.
    Yan, Hai
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (01) : 245 - 246
  • [47] Analysis of IDH1 and IDH2 mutations in Japanese glioma patients
    Sonoda, Yukihiko
    Kumabe, Toshihiro
    Nakamura, Taigen
    Saito, Ryuta
    Kanamori, Masayuki
    Yamashita, Yoji
    Suzuki, Hiroyoshi
    Tominaga, Teiji
    CANCER SCIENCE, 2009, 100 (10) : 1996 - 1998
  • [48] Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia
    Brittany Knick Ragon
    Courtney D. DiNardo
    Current Hematologic Malignancy Reports, 2017, 12 : 537 - 546
  • [49] IDH1 immunohistochemistry reactivity and mosaic IDH1 or IDH2 somatic mutations in pediatric sporadic enchondroma and enchondromatosis
    Essia Saiji
    Fabienne Gumy Pause
    Pierre Lascombes
    Christelle Cerato Biderbost
    Nathalie Lin Marq
    Margaret Berczy
    Laura Merlini
    Anne-Laure Rougemont
    Virchows Archiv, 2019, 475 : 625 - 636
  • [50] Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma
    James M. Cleary
    Betty Rouaisnel
    Antoine Daina
    Srivatsan Raghavan
    Lauren A. Roller
    Brandon M. Huffman
    Harshabad Singh
    Patrick Y. Wen
    Nabeel Bardeesy
    Vincent Zoete
    Brian M. Wolpin
    Julie-Aurore Losman
    npj Precision Oncology, 6
12345